DUE DILIGENCE SUPPORT

DUE DILIGENCE SUPPORT

Situation: A US biotech is highly interested in in-licensing a Phase IIb asset. After previous high-level reviews, full due diligence has been initiated and timelines are tight with multiple other interested competitors exploring the data room.

Approach: SCITARIS supports both technical as well as commercial Due Diligence in a stuctured, thorough and timely manner. Using our meticulous methodology, we work with the clients team to ensure all boxes have been ticked and all potential risks are flagged before closing a potential deal.

Outcome: Based on the thorough analysis of the dataroom a significant CMC hurdle and commercial constraints were flagged, which led to rational deprioritization of this opportunity and prioritization of another interesting alternative.